{"id":"W2754815061","doi":"10.1186/s12885-017-3641-6","title":"A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer","year":2017,"lang":"en","type":"article","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Internal medicine; Pharmacodynamics; Oncology; Tolerability; Pharmacokinetics; Cancer; Surgical oncology; Esophagus; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717891,0.001508459,0.002007675,0.0006065203,0.0005201639,0.0007897764,0.001016582,0.001105453,0.002340942],"category_scores_gemma":[0.0009487745,0.0006913043,0.001036996,0.0005299518,0.001073702,0.0009126558,0.0004049396,0.003411967,0.0007287616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00102899,"about_ca_system_score_gemma":0.001844235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006784173,"about_ca_topic_score_gemma":0.001703166,"domain_scores_codex":[0.9994596,0.0002601455,0.00002626106,0.00008319539,0.00006599871,0.0001049126],"domain_scores_gemma":[0.9993136,0.0001206444,0.000129832,0.00007089971,0.00004754669,0.0003175063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5099015,0.1943209,0.01388773,0.001100136,0.001547038,0.0006439002,0.0009011606,0.006458109,0.1054021,0.0004263176,0.004803951,0.1606072],"study_design_scores_gemma":[0.3750978,0.601812,0.01297672,0.00002466237,0.0002701139,0.0003888323,0.0000774248,0.001795687,0.004970648,0.00016405,0.002386861,0.00003516114],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943261,0.0009511773,0.0006623847,0.0002377696,0.00006593047,0.002362555,0.0004132039,0.00008654339,0.0008944052],"genre_scores_gemma":[0.9900833,0.0009817231,0.00262433,0.0007304674,0.0001057138,0.002839517,0.001175977,0.00002831538,0.001430499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002340942,"threshold_uncertainty_score":0.009085178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06740690104374676,"score_gpt":0.4118260559633234,"score_spread":0.3444191549195767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}